Treatment With Anakinra, a Recombinant IL-1 Receptor Antagonist, Unlikely to Induce Lasting Remission in Patients With CGD Colitis

Am J Gastroenterol. 2015 Jun;110(6):938-9. doi: 10.1038/ajg.2015.135.

¹ Department of Internal Medicine, Medstar Georgetown University Hospital, Washington, DC, USA.
² National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, Maryland, USA.
³ Laboratory of Clinical Infectious Diseases (LCID), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, Maryland, USA.
⁴ National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland, USA.
⁵ Laboratory of Host Defense (LHD), National Institutes of Health, Bethesda, Maryland, USA.

No abstract available

Publication types